2007
DOI: 10.1021/jm070653r
|View full text |Cite
|
Sign up to set email alerts
|

Design of a Potent Reactivator of Tabun-Inhibited AcetylcholinesteraseSynthesis and Evaluation of (E)-1-(4-Carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)-but-2-ene Dibromide (K203)

Abstract: Acetylcholinesterase reactivators are crucial antidotes for the treatment of organophosphate intoxication. Among the organophosphates, with the exception of soman, tabun (GA) intoxications are the least responsive to treatment with commercially available therapeutics. A rational design was used to increase reactivation ability and decrease the toxicity of the novel reactivator. (E)-1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)-but-2-ene dibromide (K203) has better properties than previously test… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
93
1

Year Published

2009
2009
2022
2022

Publication Types

Select...
8

Relationship

4
4

Authors

Journals

citations
Cited by 99 publications
(94 citation statements)
references
References 35 publications
0
93
1
Order By: Relevance
“…Therefore, the second oxime, involved into the combination, should be the oxime sufficiently effective against tabun. For our experiments, trimedoxime or the oxime K203 was chosen because trimedoxime has at least some effect against tabun-inhibited AChE (13) and the oxime K203 was found to be a promising oxime against tabun (11,19,30).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Therefore, the second oxime, involved into the combination, should be the oxime sufficiently effective against tabun. For our experiments, trimedoxime or the oxime K203 was chosen because trimedoxime has at least some effect against tabun-inhibited AChE (13) and the oxime K203 was found to be a promising oxime against tabun (11,19,30).…”
Section: Discussionmentioning
confidence: 99%
“…Although some of them can be considered to be promising oximes against some nerve agents, none of them is sufficiently effective against all nerve agents regardless of their chemical structure (28,32). Recently, the oxime K203 [1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)-but-2-ene dibromide] was synthesized at our Department of Toxicology (30) and its pharmacokinetics was studied (7). Based on in vitro and in vivo evaluation of its reactivating, therapeutic and neuroprotective efficacy, it was considered to be the promising oxime against tabun but not against cyclosarin and soman (11,12,14,15,16,19).…”
Section: Introductionmentioning
confidence: 99%
“…Since all these drawbacks have not been fully addressed so far, we still have to rely on the pyridiniumbased AChE reactivators. A few decades ago, these charged reactivators have been developed and since then only a few more with an interesting profile and concomitantly overwhelming the capability of currently used oximes have been introduced (K027 or K203) 31 . In this regard, particular attention is paid to Hlö-7 being considered one of the most potent bis-pyridinium reactivator with broad profile.…”
Section: Reactivation Of Achementioning
confidence: 99%
“…150 Many new oximes have been synthesized, and their capacities of AChE reactivation evaluated. [157][158][159][160][161][162][163][164][165][166][167][168][169][170] Figure 15 shows the structure of some of those new promising bis-pyridinium oximes. For example 1,7-heptylene-bis-N,N'-syn-2-pyridiniumaldoxime, which is 200 times more active than 2-PAM and could lead to the development of compounds able to reactivate aged phosphorylated HuAChE.…”
Section: Treatment and Antidotes For Nerve Agentsmentioning
confidence: 99%
“…158 Other examples of new promising bis-pyridinium oximes are K027 [1-(4-hydroxyiminomethylpyridinium)- 3-(4-carbamoylpyridinium) propane dibromide], K048 [1-(4-hydroxyiminomethylpyridinium)-4-(4-carbamoylpyridinium) butane dibromide], which display low toxicity against different types of human cells but have a very good capacity to reactivate HuAChE inhibited with tabun, 161,165 and similar oximes with an unsaturated liker, like K203 ((E)-1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)-but-2-ene dibromide). 166,167 There are evidences that at least some oximes (mainly HI-6 and HLö-7) also act on the treatment of intoxications through direct pharmacological effects, which are not related to AChE reactivation. However, the mechanism of these effects is not well understood yet, but there are some hypotheses.…”
Section: Treatment and Antidotes For Nerve Agentsmentioning
confidence: 99%